Inhibition of Phospholipid-Dependent Coagulation Reactions by 'Antiphospholipid Antibodies': Possible Modes of Action

Barbui T. , Cortelazzo S. , Galli M. et al. Antiphospholipid antibodies in early repeated abortions: a case-control study. Fertil Steril 1988; 50: 589-92.

Finazzi G. , Cortelazzo S. , Galli M. , Barbui T. Relative risk of recurrent abortion and thrombosis in young subjects with antiphospholipid antibodies estimated by case control studies. Postgraduate J 1989; 65: 697.

Harris EN Syndrome of the black swan. Br J Rheumatol 1987 ; 26: 324-6.

Mueller JF , Ratnoff O. , Heinle RW Observations on the characteristics of an unusual circulating anticoagulant . J Lab Clin Med 1951; 38: 254-61.

Conley CL , Hartmann RC Hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 1952; 150: 621-2.

Frick PG Acquired circulating anticoagulants in systemic collagen diseases. Autoimmune thromboplastin deficiency. Blood 1955; 10: 691-6.

Loeliger F. Prothrombin as co-factor of the circulating anticoagulant in systemic lupus erythematosus? Thromb Diath Haemorrh (Stuttg) 1959; 3: 237-56.

Yin ET , Gaston LW Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus. Thromb Diath Haemorrh (Stuttg) 1965; 14: 88-115.

Laurell AB , Nilsson IM Hypergammaglobulinemia, circulating anticoagulant and biological false positive Wassermann reaction: a study of two cases. J Lab Clin Med 1957; 49: 694-707.

Harris EN , Gharavi AE , Boey ML et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; ii: 1211-14.

Loizou S. , McCrea JD. Rudge AC et al. Measurement of anticardiolipin antibodies by enzyme-linked immunosorbent assay: standardization and quantitation of results. Clin Exp Immunol 1985 ; 62: 739-44.

Thiagarajan P. , Shapiro SS , de Marco L. A monoclonal immunoglobulin M coagulation inhibitor with phospholipid specificity: mechanism of a lupus anticoagulant . J Clin Invest 1980; 66: 397-405.

Pengo V. , Thiagarajan P. , Shapiro SS , Heine MJ Immunological specificy and mechanism of action of IgG lupus anticoagulants . Blood 1987; 70: 69-76.

Harris EN , Gharavi AE , Tincani A. et al. Affinity purified anticardiolipin and anti-DNA antibodies. J Clin Lab Immunol 1985; 17: 155-62.

Lechner K. , Pabinger-Fasching I. Lupus anticoagulant and thrombosis. Hemostasis 1985; 15: 254-62.

Exner T. , Shaman N. , Trudinger B. Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene column. Biochem Biophys Res Commun 1988; 155: 1001-7.

McNeil HP , Chesterman CN , Krilis SA Anticardiolipin antibodies and lupus anticoagulants comprise antibody subgroups with different phospholipid binding characteristics. Br J Haematol 1989; 73: 506-13.

Bevers EM , Galli M. , Barbui T. et al. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only but to a complex of lipid-bound human prothrombin. Thromb Haemostas 1991; 66: 629-32.

McNeil HP , Simpson RJ , Chesterman CN , Krilis SA Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein 1 (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4.

Galli M. , Comfurius P. , Maassen C. et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990 ; i: 1544-7.

Matsuura E. , Igarashi Y. , Fujimoto M. et al. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990 ; ii: 177-8.

Bevers EM , Galli M. β2-glycoprotein 1 for binding of anticardiolipin antibodies to cardiolipin . Lancet 1990; ii: 952-3.

Shoenfeld Y. , Meroni PL The β2-glycoprotein 1 and antiphospholipid antibodies. Workshop report. Clin Exp Rheumatol 1992; 10: 205-9.

Wagenknecht DR , McIntyre JA Changes in β2-glycoprotein 1 antigenicity induced by phospholipid binding. Thromb Haemost 1993; 69: 361-5.

Galli M. , Bevers EM , Comfurius P. et al. Effects of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles. Br J Haematol 1993 ; 83: 466-72.

Edson JR , Vogt JM , Hasegawa DK Abnormal prothrombin crossedimmunoelecrophoresis in patients with lupus inhibitors . Blood 1984; 64: 807-13.

Fleck RA , Rapaport SI , Rao Lvm. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988; 72: 512-19.

Baudo F. , Redaelli R. , Pezzetti L. et al. Prothrombin-antibody coexistent with lupus anticoagulant (LA): clinical studies and immunochemical characterization. Thromb Res 1990; 57: 279-87.

Bernini JC , Buchanan GR , Ashcroft J. Hypoprothrombinemia and severe hemorrhage associated with a lupus anticoagulant . J Pediatr 1993; 123: 937-9.

Shi W. , Chong BH , Hogg PJ , Chesterman CN Anticardiolipin antibodies block the inhibition by β2-glycoprotein 1 of the factor Xa generating activity. Thromb Haemost 1993; 70: 342-5.

Schleider MA , Nachman RL , Jaffe EA , Coleman M. A clinical study of the lupus anticoagulant . Blood 1976; 48: 499-509.

Galli M. , Comfurius P. , Barbui T. et al. Anticoagulant activity of β2-glycoprotein 1 is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost 1992; 68: 297-300.

Arvieaux J. , Roussel B. , Jacob MC et al. Measurement of antiphospholipid antibodies by ELISA using β2-glycoprotein 1 as an antigen. J lmmunol Meth 1991; 143: 223-9.

Keeling DM , Wilson Ajg , Mackie J. et al. Some 'antiphospholipid antibodies' bind to β2-glycoprotein 1 in the absence of phospholipid. Br J Haematol 1992; 82: 571-4.

Oosting JD , Derksen Rhwm , Entjes HT et al. Lupus anticoagulant activity is frequently dependent on the presence of β2-glycoprotein 1. Thromb Haemost 1992; 67: 499-502.

Viard JP , Amoura Z. , Bach JF Association of anti-β2-glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93: 181-6.

Gharavi AE , Harris NE , Sammaritano LR et al. Do patients with antiphospholipid syndrome have autoantibodies to β2-glucoprotein I? J Lab Clin Med 1993 ; 122: 426-31.

Roubey Ras , Pratt CW , Buyon JP , Winfield Ujb. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon β2-glycoprotein 1. J Clin Invest 1992; 90: 1100-4.

Arvieux J. , Pouzol P. , Roussel B. et al. Lupus-like anticoagulant properties of murine monoclonal antibodies to β2-glycoprotein 1. Br J Haematol 1992 ; 81: 568-73.

Brandt JT Antibodies to β2-glycoprotein 1 inhibit phospholipid dependent coagulation reactions. Thromb Haemost 1993 ; 70: 598-602.

Oosting JD , Derksen Rhwm , Bobbink Iwg et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S: an explanation for their pathogenic mechanisms. Blood 1993; 81: 2618-25.